NRG Oncology reports that its NRG-GOG 0258 clinical trial demonstrates that carboplatin and paclitaxel chemotherapy preceded by radiotherapy with concurrent cisplatin, or combined modality therapy did not significantly increase recurrence-free survival for women with...